SEC Nets $9.8M From AWOL Sanofi Insider Trading Suspect
A New York federal judge ruled Wednesday that a Swiss businessman ignoring civil and criminal cases accusing him of engaging in insider trading ahead of Sanofi SA's acquisition of Bioverativ Inc....To view the full article, register now.
Already a subscriber? Click here to view full article